Tarsus Pharmaceuticals Overview
Tarsus Pharmaceuticals Target Price
Analysts' 12-month price predictions for TARS.
Get informed when a big investor buys or sells
+ FollowShare Price
$65.44
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-02-05 | Goldman Sachs | $68 |  3.9% upside |  |
| 2025-12-08 | Barclays | $100 | 52.8% upside | |
| 2025-11-20 | Mizuho Securities | $100 | 52.8% upside | |
| 2025-11-06 | Goldman SachsAndrea Tan | $51 |  22.1% downside | |
| 2025-10-20 | H.C. Wainwright | $88 | 34.5% upside | |
| 2025-05-02 | GuggenheimEddie Hickman | $84 | 28.4% upside | |
| 2025-03-06 | Jefferies | $58 | 11.4% downside | |
| 2025-01-27 | BarclaysBalaji Prasad | $62 | 5.3% downside | |
| 2025-01-22 | OppenheimerFrancois Brisebois | $72 | 10% upside | |
| 2024-09-23 | OppenheimerFrancois Brisebois | $63 | 3.7% downside | |
| 2024-05-13 | H.C. WainwrightOren Livnat | $61 | 6.8% downside | |